Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint Pecenka

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
BMJ Open|October 5, 2022
Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccinesFrédéric Debellut, Kevin Tang, Andrew Clark, et al.
Vaccine|December 11, 2017
Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031Justice Nonvignon, Deborah Atherly, Clint Pecenka, et al.
Vaccine|July 25, 2021
The projected cost-effectiveness and budget impact of HPV vaccine introduction in GhanaElisabeth Vodicka, Justice Nonvignon, Kwadwo Odei Antwi-Agyei, et al.
Health Affairs (Project Hope)|February 10, 2016
Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine IntroductionAngela K Shen, Jonathan M Weiss, Jon Kim Andrus, et al.
The Lancet. Global Health|May 18, 2023
Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling studyChloe Puett, John D Anderson, Karoun H Bagamian, et al.
Vaccine|August 18, 2024
Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in ArgentinaGonzalo Guiñazú, Julia Dvorkin, Sarwat Mahmud, et al.
Journal of Global Health|April 30, 2026
Impact and cost-effectiveness of two interventions to prevent paediatric respiratory syncytial virus disease in Cameroon: a modelling approachFarina Leonie Shaaban, Norbert Fuhngwa, Henshaw Mandi, et al.
Frontiers in Public Health|April 6, 2026
Antibiotic use in respiratory syncytial virus-positive children under two years: a prospective observational study at a tertiary hospital in GhanaJoycelyn Assimeng Dame, Kwabena Agyapong Osman, An Nguyen, et al.
Vaccine|September 1, 2025
Valuing combination vaccines: an incomplete picture and a pathway to a broader viewFrédéric Debellut, Mark Jit, Allison Portnoy, et al.
The Lancet. Global Health|November 12, 2019
Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling studyFrédéric Debellut, Andrew Clark, Clint Pecenka, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
BMJ Open|October 5, 2022
Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccinesFrédéric Debellut, Kevin Tang, Andrew Clark, et al.
Vaccine|December 11, 2017
Cost-effectiveness of rotavirus vaccination in Ghana: Examining impacts from 2012 to 2031Justice Nonvignon, Deborah Atherly, Clint Pecenka, et al.
Vaccine|July 25, 2021
The projected cost-effectiveness and budget impact of HPV vaccine introduction in GhanaElisabeth Vodicka, Justice Nonvignon, Kwadwo Odei Antwi-Agyei, et al.
Health Affairs (Project Hope)|February 10, 2016
Country Ownership And Gavi Transition: Comprehensive Approaches To Supporting New Vaccine IntroductionAngela K Shen, Jonathan M Weiss, Jon Kim Andrus, et al.
The Lancet. Global Health|May 18, 2023
Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling studyChloe Puett, John D Anderson, Karoun H Bagamian, et al.
Vaccine|August 18, 2024
Evaluation of the potential impact and cost-effectiveness of respiratory syncytial virus (RSV) prevention strategies for infants in ArgentinaGonzalo Guiñazú, Julia Dvorkin, Sarwat Mahmud, et al.
Journal of Global Health|April 30, 2026
Impact and cost-effectiveness of two interventions to prevent paediatric respiratory syncytial virus disease in Cameroon: a modelling approachFarina Leonie Shaaban, Norbert Fuhngwa, Henshaw Mandi, et al.
Frontiers in Public Health|April 6, 2026
Antibiotic use in respiratory syncytial virus-positive children under two years: a prospective observational study at a tertiary hospital in GhanaJoycelyn Assimeng Dame, Kwabena Agyapong Osman, An Nguyen, et al.
Vaccine|September 1, 2025
Valuing combination vaccines: an incomplete picture and a pathway to a broader viewFrédéric Debellut, Mark Jit, Allison Portnoy, et al.
The Lancet. Global Health|November 12, 2019
Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling studyFrédéric Debellut, Andrew Clark, Clint Pecenka, et al.
Pageof 10